Helmholtz Diabetes Center
Institute of Diabetes Research
The Institute of Diabetes Research (IDF) is dedicated to studying the natural history of type 1 diabetes, identifying mechanisms and predictive markers of the disease, investigating the pathology of the human pancreas, and implementing novel treatment approaches in clinical trials to prevent type 1 diabetes.
The Institute of Diabetes Research (IDF) is dedicated to studying the natural history of type 1 diabetes, identifying mechanisms and predictive markers of the disease, investigating the pathology of the human pancreas, and implementing novel treatment approaches in clinical trials to prevent type 1 diabetes.
Research Areas
Research Platforms
Currently Recruiting
Publications
Rosenzwajg, M. ; Hartemann, A. ; Halbron, M. ; Amouyal, C. ; Thivolet, C. ; Rigalleau, V. ; Fontaine, P. ; Mignot, B. ; Reynaud, R. ; Carel, J.C. ; Bismuth, E. ; Storey, C. ; Bourdet, K. ; Sonnet, E. ; Baron, S. ; Nicolino, M. ; Perge, K. ; Chaillous, L. ; Kessler, L. ; Mansilla, M. ; Achenbach, P. ; Ziegler, A.-G. ; Aanstoot, H.J. ; Mouraux, T. ; Casteels, K. ; Donath, M.Y. ; Roep, B.O. ; Lorenzon, R. ; Ribet, C. ; Salem, J.E. ; Pitoiset, F. ; Roux, A. ; Vicaut, E. ; Klatzmann, D.
Efficacy and safety of low-dose IL-2 in people with newly diagnosed type 1 diabetes (DIABIL-2): A double-blind, multicentre, randomised, placebo-controlled, phase 2b trial.Wyatt, R.C. ; Brigatti, C. ; Grace, S.L. ; Williams, C.L. ; Marzinotto, I. ; Gillard, B.T. ; Bazzigaluppi, E. ; Shoemark, D. ; Chandler, M.A. ; Achenbach, P. ; Piemonti, L. ; Gillespie, K.M. ; Lampasona, V. ; Williams, A.J.K. ; Tyler, J. ; Long, A.E.
In response to comment on improved prediction of symptomatic type 1 diabetes using a luciferase-based assay to measure (pro) insulin autoantibodies.Dong, D. ; Walsh, A.M. ; Vatanen, T. ; Weingart, G. ; Khdhiri, M. ; Stampfer, M.J. ; Vehik, K. ; Franzosa, E.A. ; Huttenhower, C. ; Wang, D.D. ; TEDDY Study Group (Ziegler, A.-G. ; Sanverdi, C. ; Heublein, A. ; Hummel, S. ; Knopff, A. ; Köger, M. ; Ramminger, C. ; Roth, R. ; Schmidt, J. ; Scholz, M. ; Stock, J. ; Warncke, K. ; Müller, L. ; Winkler, C.)
Gut microbiome maturation in early childhood interacts with host genetics to predict type 1 diabetes risk.Ziegler, A.-G. ; Rewers, M.J. ; Achenbach, P. ; Bell, K.J. ; Bonifacio, E. ; DiMeglio, L.A. ; Dutta, S. ; Larsson, H.E. ; Frohnert, B.I. ; Griffin, K. ; Hagopian, W.A. ; Jacobsen, L.M. ; Lange, K. ; Mallone, R. ; Narendran, P. ; Oron, T. ; Rich, S.S. ; McDonough, C.W. ; Schweiger, D.S. ; Zdenĕk Šumnı́k, ; Szypowska, A. ; Veijola, R. ; Vercauteren, J. ; Wentworth, J.M. ; Wherrett, D.K. ; Albanese-O’Neill, A.
International consensus guidance for general population screening for islet autoantibodies to diagnose early-stage type 1 diabetes: A nominal group technique process.Rojas López, M.B. ; Gehmeyr, M. ; Nitkunanantharajah, S. ; Preissl, H. ; Vosseler, A. ; Jumpertz von Schwartzenberg, R. ; Birkenfeld, A.L. ; Katsouli, N. ; Fasoula, N.-A. ; Karlas, A. ; Kallmayer, M. ; Branzan, D. ; Ziegler, A.-G. ; Jüstel, D. ; Ntziachristos, V.
Real-time quality control in optoacoustic mesoscopy for enhancing data quality and standardization in clinical studies.Networks & Affiliations
Team
Institute Director, Chair of Diabetes and Gestational Diabetes, Klinikum rechts der Isar and Technical University of Munich, Director of the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD)
View profileDeputy Director, Lead Scientist Research Area: Study Center for Childhood Diabetes
View profileLead Scientist Research Area: Lifestyle, Obesity, and Epigenetic Programming in Type 1 and Gestational Diabetes
View profileLead Scientist Research Area: Early Diagnosis & Staging of Type 1 Diabetes, and Phenotyping
View profileLead Scientist Research Area: Computational Biology and Immune Response Trajectories of Type 1 Diabetes Development
View profileLead Scientist Research Area: Digital Networking for Type 1 Diabetes Research
View profileContact
Institute Director, Chair of Diabetes and Gestational Diabetes, Klinikum rechts der Isar and Technical University of Munich, Director of the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD)
anettegabriele.zieglerspam prevention@helmholtz-munich.de Website
Heidemannstraße 1, 80939 München
Deputy Director, Lead Scientist Research Area: Study Center for Childhood Diabetes
peter.achenbachspam prevention@helmholtz-munich.de
Heidemannstraße 1, 80939 München